Sarcoma: open trials in United States

301 open trials have a site in United States. Registry data; only the trial team decides who can take part.

NCT05301283
Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma
Trial Treatment · Phase 2 · H. Lee Moffitt Cancer Center and Research Institute
Moffitt Cancer Center, Tampa
Registry updated 2025-12-04
NCT01050296
Molecular Analysis Of Solid Tumors
Research · St. Jude Children's Research Hospital
St. Jude Children's Research Hospital, Memphis
Registry updated 2025-11-12
NCT07129317
Pediatric Radiation Therapy Registry
Research · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Johns Hopkins Hospital, Baltimore · Sibley Memorial Hospital, Washington D.C.
Registry updated 2025-11-05
NCT07224568
Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors
Trial Treatment · Phase 1 · Seattle Children's Hospital
Fred Hutch Cancer Center, Seattle
Registry updated 2025-11-04
NCT06198296
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Trial Treatment · Phase 1 · Baylor College of Medicine
Houston Methodist Hospital, Houston
Registry updated 2025-11-03
NCT07058064
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
Trial Treatment · Mayo Clinic
Mayo Clinic in Rochester, Rochester
Registry updated 2025-10-15
NCT06812052
Short Course Radiation Treatment for Patients With Primary or Locally Recurrent Retroperitoneal Sarcoma Prior to Surgery
Trial Treatment · Phase 1 · Brigham and Women's Hospital
Brigham and Women's Hospital / Dana-Farber Cancer Institute, Boston
Registry updated 2025-10-14
NCT06712810
Q702 for the Treatment of Patients With Hematologic Malignancies
Trial Treatment · Phase 1 · Mayo Clinic
Mayo Clinic in Rochester, Rochester · Mayo Clinic in Arizona, Scottsdale
Registry updated 2025-10-10
NCT04370587
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 1/2 · ImmVira Pharma Co. Ltd
Massachusetts General Hospital, Boston · Dana-Farber Cancer Institute, Boston · Mary Crowley Cancer Research, Dallas · Virginia Cancer Specialists, Fairfax · Banner MD Anderson Cancer Center, Gilbert · University of Pittsburgh Medical Center, Pittsburgh
Registry updated 2025-10-08
NCT06482957
Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
Research · Vanderbilt-Ingram Cancer Center
Vanderbilt University/Ingram Cancer Center, Nashville
Registry updated 2025-09-19
NCT05135975
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Trial Treatment · Phase 2 · Nationwide Children's Hospital
Children's Hospital of Colorado, Aurora · Children's Hospital of Alabama/UAB, Birmingham · Nationwide Children's Hospital, Columbus · Primary Children's Hospital, Salt Lake City · Children's Hospital at Montefiore, The Bronx · Children's National Medical Center, Washington D.C.
Registry updated 2025-08-12
NCT06298916
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Trial Treatment · Phase 1/2 · Lantheus Medical Imaging
Cincinnati Children's Hospital Medical Center, Cincinnati · City of Hope, Duarte · BAMF Health Inc., Grand Rapids · UC Irvine Health- Chao Family Comprehensive Cancer Center, Orange · Stanford Hospital & Clinics, Stanford
Registry updated 2025-08-12
NCT06700070
A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors
Trial Treatment · Early phase 1 · Pure Biologics S.A.
LSU Health Sciences Center, Shreveport
Registry updated 2025-08-11
NCT06875700
Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients
Research · University of Utah
Huntsman Cancer Institute at the University of Utah, Salt Lake City
Registry updated 2025-06-13
NCT04506008
Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas
Trial Treatment · Phase 2 · Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center, Nashville
Registry updated 2025-03-28
NCT06887673
Lipid Mediators & Cancer: Montelukast, SPM, and Almonds
Trial Treatment · Early phase 1 · University of South Florida
Tampa General Hospital, Tampa · University of South Florida, Tampa
Registry updated 2025-03-20
NCT00005095
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Research · Northwestern University
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago
Registry updated 2025-02-28
NCT03138161
SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma
Trial Treatment · Phase 1/2 · Sarcoma Oncology Research Center, LLC
Sarcoma Oncology Research Center, Santa Monica
Registry updated 2025-02-24
NCT03886311
Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma
Trial Treatment · Phase 2 · Sarcoma Oncology Research Center, LLC
Sarcoma Oncology Center, Santa Monica
Registry updated 2025-02-24
NCT04535271
Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma
Trial Treatment · Phase 2 · Sarcoma Oncology Research Center, LLC
Sant P Chawla, Santa Monica
Registry updated 2025-02-24
NCT06272864
BostonGene and Exigent Genomic INsight Study
Research · BostonGene
New Mexico Cancer Center, Albuquerque · Fort Wayne Medical Oncology and Hematology, Fort Wayne · Oncology Consultants, Houston · Northwest Medical Specialities, Puyallup · Highlands Oncology Group, Rogers · Stockton Hematology Oncology Medical Group, Stockton · Oklahoma Cancer Specialists and Research Institute, Tulsa
Registry updated 2025-02-17
NCT06748872
EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma
Trial Treatment · Phase 1 · Medigene AG
Fred Hutch Cancer Center, Seattle
Registry updated 2024-12-27
NCT05824975
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Trial Treatment · Phase 1/2 · GI Innovation, Inc.
Cleveland Clinic, Cleveland · Mayo Clinic in Florida, Jacksonville · Memorial Sloan-Kettering Cancer Center, New York · Mayo Clinic in Minnesota, Rochester · Mayo Clinic in Arizona, Scottsdale
Registry updated 2024-11-25
NCT06436846
Genomic Risk in Retroperitoneal Sarcoma
Research · Fox Chase Cancer Center
Fox Chase Cancer Center, Philadelphia
Registry updated 2024-05-31
NCT06264505
Investigative Analysis of Soft Tissue Sarcoma Clinical Trials: An Observational Study
Research · Power Life Sciences Inc.
Power Life Sciences, San Francisco
Registry updated 2024-02-28

All Sarcoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error